The subunit composition of N-methyl D-aspartate receptors (NMDARs) is tightly regulated during cortical development. NMDARs are initially dominated by GluN2B (NR2B), whereas GluN2A (NR2A) incorporation increases after birth. The function of GluN2B-containing NMDARs during development, however, is incompletely understood. We generated a mouse in which we genetically replaced GluN2B with GluN2A (2B/2A). Although this manipulation restored NMDAR-mediated currents at glutamatergic synapses, it did not rescue GluN2B loss of function. Protein translation-dependent homeostatic synaptic plasticity is occluded in the absence of GluN2B, and AMPA receptor contribution is enriched at excitatory cortical synapses. Our experiments indicate that specificity of GluN2B-mediated signaling is due to its unique interaction with the protein effector alpha calcium-calmodulin kinase II and the regulation of the mTOR pathway. Homozygous 2B/2A mice exhibited high rates of lethality, suppressed feeding, and depressed social exploratory behavior. These experiments indicate that GluN2B-containing NMDARs activate unique cellular processes that cannot be rescued by replacement with GluN2A.
INTRODUCTION
Glutamatergic synapses provide the majority of excitatory neurotransmission in the brain, and the ionotropic receptors responsible for rapid information transfer at these contacts are N-methyl D-aspartate receptors (NMDARs) and a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs). NMDAR activation results in calcium-ion influx, which links synapse activation to intracellular signaling cascades which control synaptic strength, neuronal excitability, and neuronal survival. NMDARs are heteromultimeric protein complexes containing two GluN1 subunits (a single gene) and two GluN2 (NR2) subunits, which are encoded by four genes in mammals (GluN2A-D; also known as NR2A-D) (Meguro et al., 1992; Monyer et al., 1992) . Contribution of GluN2 subunits to the NMDAR complex is precisely regulated during development, with early postnatal receptors containing exclusively GluN2B subunits, whereas increased incorporation of GluN2A subunits occurs during a postnatal period of synapse maturation and cortical circuit refinement (Monyer et al., 1994; Sheng et al., 1994) .
Homozygous GluN2B genetic knockout (KO) animals die on postnatal day 0 (P0) (Kutsuwada et al., 1996) . By contrast, GluN2A knockout animals are viable and fertile (Sakimura et al., 1995) . Due in part to the lethality of the GluN2B knockout mutation, the role of this receptor subtype during development remains unclear. In addition, the relative role of GluN2B-versus GluN2A-containing NMDARs in synapse function has become a highly debated issue, with potentially distinct roles ascribed to these receptors in regimes of synaptic plasticity and metaplasticity (Yashiro and Philpot, 2008) . Assigning unique functional roles to GluN2B-containing NMDARs during development is complicated by the fact that their exclusive expression means that specific loss of GluN2B also results in total loss of NMDAR signaling during this period. This poses a problem for interpretation of data from GluN2B loss-of-function experiments during postnatal development: which aspects of the loss-of-function phenotype are due to loss of GluN2B signaling specifically, and which are due to loss of NMDAR signaling generally? To answer this question and improve our knowledge of the distinct roles that GluN2B-containing NMDARs play in regulating synapse function, we genetically replaced GluN2B with GluN2A in mice (2B/2A). In these 2B/2A allelic ''replacement'' animals, functional NMDAR current is recovered during postnatal development, but the current is now mediated by GluN2A-containing receptors in the absence of GluN2B.
We show here that premature expression of GluN2A is unable to rescue GluN2B loss of function, demonstrating that this period of GluN2B predominance is critical. Homozygous 2B/2A animals suffer high rates of lethality, a dramatically suppressed suckling reflex, and retarded body growth. This phenotype was observed despite the fact that NMDAR-mediated currents were rescued to comparable levels at excitatory cortical synapses. Our experiments show that GluN2B-mediated signaling is specifically required for proper AMPAR regulation at developing cortical synapses, and loss of GluN2B occludes protein translation-dependent homeostatic synaptic plasticity in these neurons. Furthermore, we show that this is likely due to the unique association between GluN2B and alpha calciumcalmodulin kinase II (CaMKII) and involves regulation of the mammalian/mechanistic target of rapamycin (mTOR) pathway. The behavioral phenotype of homozygous 2B/2A mice includes reduced social exploration in spite of exhibiting hyperlocomotion. In summary, our experiments reveal a critical role for GluN2B-mediated NMDAR signaling in regulating cortical synapse development and protein translation-dependent homeostatic synaptic plasticity, as well as show that selective loss of GluN2B function during development results in behaviors consistent with mouse models of schizophrenia.
RESULTS

Generation and Characterization of the 2B/2A Mouse
To test the role of GluN2B-containing NMDARs during development, we generated a GluN2B-to-GluN2A ''replacement'' mouse (2B/2A). The genetic strategy is shown in Figure 1A . The first coding exon of GluN2B (exon 4) was disrupted and replaced with cDNA encoding GluN2A as well as a neomycin resistance selection cassette. Following targeted homologous recombination, selection of properly targeted embryonic stem cells, and generation of confirmed founder animals, the neomycin cassette was removed by crossing animals with a protamine-driven Crerecombinase mouse line (JAX: 003328). Double heterozygous (HET) male mice, containing a copy of the protamine-CRE transgene and a copy of the 2B/2A allele, were mated with C57/BL6 wild-type (WT) female mice. PCR-based genotyping differentiated between 2B/2A and WT GluN2B alleles and confirmed removal of the neomycin selection cassette ( Figure 1B ). Western blot analysis of cortical neuronal lysates, both in vitro and in vivo, showed that GluN2A protein is expressed prematurely in this animal in lieu of GluN2B (Figures 1C, 1D, and 1F) . Western blot analysis during development confirmed the continued absence of GluN2B and the premature expression of GluN2A in 2B/2A cortical neurons (see Figure S1 available online). RT-PCR analysis of mRNA harvested from P17 homozygous 2B/2A animals showed the absence of GluN2B transcript and replacement with exogenous rat mRNA encoding GluN2A, in addition to the endogenous mouse transcript ( Figure 1E ). Together, these data show that the genetic strategy was successful and predict that in homozygous 2B/2A animals, glutamatergic cortical synapses contain only GluN2A-containing receptors within a GluN2B null background.
Genetic deletion of GluN2B leads to perinatal lethality (Kutsuwada et al., 1996) . 2B/2A mice also displayed a high rate of perinatal lethality, indicating that premature expression of GluN2A is not sufficient to fully rescue GluN2B loss of function. Genotyping embryos harvested to prepare cortical cultures showed that the transmission frequency of the 2B/2A allele followed a predicted pattern with an approximately 1:2:1 (WT:HET:2A/2B) ratio from matings between heterozygous 2B/2A animals (19:41:21, in ten cultures). However, only z8% of 2A/2B homozygous animals survived past P0: 6 out of 72 predicted animals (24 months following removal of the neo cassette, data from 38 litters). Surviving homozygous 2B/2A pups exhibited no differences in size at P0 but were significantly stunted in mass when measured as juveniles (P12-P16) ( Figures  1G and 1H ). In homozygous 2B/2A pups at P0, we recorded a decrease in the number of rhythmic mouth suckling movements in response to stimulation with a feeding needle ( Figure 1I ), suggestive of a weakened ability to feed. This is consistent with an observed lack of milk in their bellies at this age ( Figure 1G ) and is similar to the GluN2B full knockout animals, which show a complete absence of suckling behavior.
Recovery of Surface NMDARs in 2B/2A Neurons
These observations underscore the importance of NMDAR signaling during development but also suggest a required and specific role for GluN2B-containing NMDARs. To determine whether or not GluN2A-containing receptors were properly expressed and trafficked to the neuronal membrane in 2B/2A mice, we generated neuronal cultures from homozygous embryos as well as WT embryos at E16-E17 and performed immunofluorescence analysis of GluN1. GluN1 is the obligate subunit of the NMDAR, and thus its expression in dendrites will correlate positively with total receptor levels. We measured similar levels of anti-GluN1 staining in 2B/2A dendrites compared to WT controls by costaining with the dendritic marker MAP2 (Figure 2A ). To examine surface-localized protein, we used a live-labeling protocol. This analysis showed that the amount of membrane-associated GluN1 protein in 2B/2A neurons was comparable to WT ( Figure 2B ). Because GluN1 subunits do not traffic to the neuronal surface in the absence of GluN2 (Horak et al., 2008) this suggests that levels of surface membrane receptors are similar between genotypes. We also observed comparable levels of GluN1 staining intensity in 2B/2A neurons when we examined the signal that colocalized with the excitatory synapse marker VGluT1, suggesting that levels of synaptically localized receptors are also comparable ( Figures 2B and S2A) .
To confirm the presence of functional NMDARs on these neurons, we applied localized NMDA stimulation (100 mM NMDA + 10 mM D-serine) while recording from voltage-clamped neurons at a holding potential of +50mV ( Figure 2C ). This allowed us to investigate surface receptor responses independent of presynaptic release. Interestingly, stimulation durations required to evoke similar current amplitudes were higher for 2B/2A neurons, and the peak amplitudes of these responses were slightly lower than control neurons at similar stimulation durations ( Figure 2D ). Although this suggested a decrease in the number of functional surface receptors, it is also consistent with the observation that GluN2A-containing NMDARs have lower agonist sensitivity than GluN2B (Erreger et al., 2007) . In (B) Live labeling revealed similar levels of surface-localized GluN1, whereas colocalization with the presynaptic marker VGluT1 revealed a slight increase in GluN1 putatively localized to synaptic sites in 2B/2A dendrites. (C) Local application of NMDA (100 mM) and D-Serine (10 mM) evoked outward currents in WT and 2B/2A neurons voltage clamped at +50mV. These currents were sensitive to the NMDAR antagonist MK801. (D) For similar stimulus duration, currents in 2B/2A neurons were slightly depressed in terms of their peak amplitude. (E) These NMDAR-mediated currents showed similar rates of use-dependent block in response to MK801 application and no difference in COV values, which increased predictably in both genotypes as the population of activated receptors decreased (cf. 0 min and 8 min of MK801 application). (F) Consistent with a pure population of GluN2A-containing NMDARs, responses evoked in 2B/2A neurons were insensitive to the GluN2B selective antagonist ifenprodil but significantly more sensitive to the zinc ion chelator TPEN. support of this, we noted that when NMDA concentration was increased (1 mM), response amplitudes were not significantly different ( Figure S2B ). To further estimate the number of functional membrane receptors, we applied coefficient of variance (COV) analysis to the NMDA-evoked responses. As predicted, application of the use-dependent NMDAR antagonist MK801 caused an increase in COV over time ( Figures 2C and 2E) . However, we observed no significant difference in COV values between WT and 2B/2A neurons at either high or low levels of receptor blockade ( Figure 2E ). Single-channel recordings in expression systems have shown that heteromeric GluN1/ GluN2A NMDARs exhibit higher open probability than GluN1/ GluN2B NMDARs, which predict a faster rate of block by MK801 (Erreger et al., 2005; Chen et al., 1999) . However, our observations are consistent with other results in neurons (Speed and Dobrunz, 2009; Chavis and Westbrook, 2001 ) and suggest that, unlike in expression systems, GluN2A-containing NMDARs in cortical neurons may have similar open channel probabilities compared to those containing GluN2B. The pharmacological profile of NMDAR currents in 2B/2A neurons was consistent with a pure GluN2A-containing population because they were insensitive to the GluN2B antagonist ifenprodil (3 mM), whereas WT responses were blocked to nearly 50% ( Figure 2F ). GluN2A-containing NMDARs are also more sensitive to ambient zinc ions, and we observed that 2B/2A responses exhibited significantly more potentiation following application of the zincion chelator TPEN (0.5 mM) ( Figure 2F ). Together, these data indicate that GluN2A protein is expressed and, along with GluN1, is able to form functional receptors in the absence of GluN2B. Moreover, they suggest the presence of similar numbers of NMDARs on 2B/2A neurons, although peak amplitudes of NMDA-evoked currents were depressed, potentially due to the dominance of extrasynaptic receptors to responses evoked under this stimulation method and/or to decreased agonist sensitivity of GluN2A-containing NMDARs.
Recovery of Synaptic NMDARs in 2B/2A Neurons
Responses evoked by localized NMDA application in vitro are the result of activation of both synaptic and extrasynaptic receptors. We next carried out experiments in acute slices to confirm the presence of synaptic NMDAR-mediated currents ex vivo. GluN2A-containing NMDARs have been shown to traffic to autaptic synapses in GluN2B null hippocampal cultures and in cultured cortical slices following knockdown of GluN2B (Tovar et al., 2000; Barria and Malinow, 2002) . However, their ability to traffic to GluN2B null synapses in vivo had not been tested. We recorded whole-cell currents from layer II/III cortical neurons in acute brain slices in response to presynaptic stimulation in layer IV of 2B/2A animals (P12-P16) ( Figure 3 ). Voltage clamping at depolarized potentials to remove the Mg 2+ block of NMDARs and electrically stimulating afferent axons allowed us to record APV-sensitive currents in 2B/2A cortex (Figures 3A and 3B) . The peak amplitude of the synaptic NMDAR-mediated current at +50mV was not significantly different in 2B/2A mice compared to controls ( Figure 3B ). Consistent with a pure population of GluN2A-containing receptors, these recordings revealed a lack of sensitivity to the GluN2B selective antagonist ifenprodil ( Figure 3C ) and to NMDAR-mediated currents that exhibited significantly faster decay times (decreased tau) (Figure 3D) (Vicini et al., 1998) . Faster decay resulted in a slight, but statistically significant, decrease in integrated current measured at +50mV over the initial 200 ms of the evoked response, but not over the initial 100 ms of the response (Figure 3D ). These data show that our genetic strategy was successful in removing GluN2B and driving precocious expression and synaptic incorporation of GluN2A-mediated NMDAR-receptors while recovering a significant amount of synaptic NMDAR-mediated current at cortical synapses in vivo.
GluN2B-Mediated Signaling Is Required for Proper AMPAR Regulation and Homeostatic Synaptic Plasticity in Developing Cortical Networks
GluN2B and GluN2A interact with, and activate, distinct signaling cascades at excitatory synapses in order to control the composition and strength of synaptic contacts. The dominant way by which NMDARs regulate synaptic strength is through bidirectional trafficking of AMPARs. In light of this, we examined AMPAR-mediated currents in 2B/2A mice. For these experiments, cortical neuron cultures were prepared from both homozygous GluN2B knockout and 2B/2A embryos, as well as from WT littermate embryos. We isolated AMPAR-mediated miniature excitatory postsynaptic currents (mEPSCs) between 11 and 15 days in vitro (DIV) using 0.5 mM tetrodotoxin (TTX) + 50 mM picrotoxin. In both GluN2B null and 2B/2A cultures, we observed a significant increase in mean mEPSC amplitudes ( Figure 4A ), showing that individual cortical synapses had enriched AMPAR contribution in the absence of GluN2B. This is consistent with published data showing that NMDAR signaling, under basal levels of activity, can act to suppress incorporation of AMPARs at glutamatergic synapses Ultanir et al., 2007; Hall and Ghosh, 2008; Adesnik et al., 2008; Engblom et al., 2008) . The inability of GluN2A to rescue mEPSC amplitudes in 2B/ 2A neurons predicts a unique role for GluN2B-containing NMDARs in regulating AMPAR current development in cortical neurons. The increase in mEPSC amplitudes, both in GluN2B null and 2B/2A neurons, was multiplicative (slope: GluN2B null = 1.85, R = 0.984; 2B/2A = 1.64, R = 0.99) ( Figure 4A ). This predicted a proportionate enrichment of AMPARs across all synapses, which is a hallmark of synaptic scaling (Turrigiano, 2008) . This led us to believe that GluN2B might be important for controlling homeostatic synaptic plasticity. Proper circuit formation requires homeostatic plasticity, which drives cell-wide changes in synaptic strength in part by regulating AMPAR contribution. Homeostatic changes in synaptic strength can be measured as changes in AMPAR-mediated mEPSC amplitudes (Turrigiano, 2008) . Synaptic scaling, evoked in response to manipulation of activity levels in neuronal cultures, can be transcription dependent or protein translation dependent, and the effect on individual neurons can vary depending upon cell type and age in culture (Desai et al., 2002; Wierenga et al., 2005; Sutton et al., 2006; Turrigiano, 2008) . We were able to consistently scale up AMPAR-mediated mEPSC amplitudes in WT cortical pyramidal neurons between 11 and 15DIV, in response to chronic activity blockade (24 hr 2 mM TTX) (control = 10.68 ± 0.30 pA, n = 38; TTX = 16.13 ± 0.64 pA, n = 13; p < 0.001) and
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Developmental Role of GluN2B-Containing NMDARs in response to acute activity blockade (5 hr 2 mM TTX concurrent with 4 hr of 50 mM APV treatment) (TTX + APV = 14.56 ± 0.86 pA, n = 13; p < 0.001) (Figures 4B and 4C) , consistent with previous reports (Turrigiano et al., 1998; Sutton et al., 2006; Aoto et al., 2008) .
We next examined the role of GluN2B-containing NMDARs in these regimes of homeostatic plasticity by comparing WT, GluN2B KO, and 2B/2A replacement neurons. In both GluN2B knockout neurons and homozygous 2B/2A neurons, scaling in response to chronic (24 hr) TTX treatment was intact at holding potentials of À70mV and +50mV to isolate AMPAR-mediated and AMPAR + NMDAR-mediated current, respectively, for both WT and 2B/2A slices (P16). (B) In homozygous 2B/2A animals, current at +50mV was strongly suppressed by APV, demonstrating the functional recovery of NMDAR-mediated current. Cumulative data revealed that peak current amplitudes at +50mV were similar in 2B/2A slices. (C) This synaptic current in 2B/2A slices was insensitive to the GluN2B specific antagonist ifenprodil, consistent with a switch from GluN2B-to GluN2A-containing NMDARs. (D) Replacement of GluN2B with GluN2A in these animals resulted in a predicted and significant decrease in the decay time constant of the current response at +50mV, resulting in suppression of integrated current when measured over 200 ms. These data show that AMPARs and GluN2A-containing NMDARs are present at cortical synapses in the absence of GluN2B in the 2B/2A replacement mice. (B) Cultures were tested for their ability to respond to both chronic and acute suppression of neuronal activity. The experimental design is shown schematically (left) and representative whole-cell voltage-clamp recordings under each condition are presented (right). Traces are 30 s of spontaneous synaptic activity in the presence of TTX + picrotoxin at a holding potential of À65mV. (C) Cumulative data reveal the significant increase in mean mEPSC event amplitudes in both GluN2B and 2B/2A knockout cultures compared to age-matched controls. The ability to scale up mEPSC amplitudes in response to chronic TTX treatment (24 hr TTX) was intact in all three genotypes. However, synaptic scaling in response to acute TTX and APV treatment (5 hr TTX + 2 hr APV) was occluded in the absence of GluN2B (KO) and was not rescued by genetic replacement with GluN2A (2B/2A).
Developmental Role of GluN2B-Containing NMDARs (+36% GluN2B KO, p < 0.001; +19% 2B/2A, p < 0.05) (Figure 4C) . However, activation of NMDARs even in the presence of TTX can suppress local protein translation, and removing this suppression results in a rapid multiplicative scaling up of synapses. This form of scaling is mediated by novel protein synthesis and can be evoked in response to acute treatment with TTX and APV (5 hr TTX + 4 hr concurrent APV treatment; see Figures 4B and 4C) . In our experiments, acute treatment with TTX and APV in WT neurons caused a 36% increase in mEPSC amplitudes, consistent with previous results (Sutton et al., 2006; Aoto et al., 2008) . Additionally, we observed that this was predominantly due to an initial increase in the presence of GluA1 (GluR1)-containing AMPARs ( Figure S4 ), which are replaced over time by GluA2. Interestingly, this form of homeostatic plasticity was occluded in both GluN2B knockout (101% ± 3.8%, p = 0.82) and 2B/2A (100.5% ± 3.2%, p = 0.93) cultures ( Figure 4C ).
To confirm these results, we attempted to rescue the increase in mEPSC amplitudes by cotransfecting GluN2A or GluN2B into GluN2B null neurons. In these experiments, only GluN2B recovered mEPSC amplitudes to WT control levels, and transfection of GluN2B into 2B/2A neurons also returned mEPSC amplitudes to control levels ( Figure 5A ). Treatment with TTX and ifenprodil (3 mM) also increased mEPSC amplitudes, supporting a role for GluN2B-containing receptors in this protein translation-dependent scaling regime ( Figure 5B ). Interestingly, coapplication of actinomycin-D (12 mM) blocked scaling in response to 24 hr TTX ( Figure 5C ), in line with previous observations suggesting that synaptic scaling in response to chronic manipulation requires transcriptional activation (Turrigiano et al., 1998) . To confirm a role for protein translation in the rapid scaling regime, we also observed that coapplication of the translation inhibitor anisomycin (40 mM) blocked the increase in mEPSC amplitudes observed with TTX + APV alone ( Figure 5C ). Furthermore, the protein translation blocker cycloheximide (100 mM, 24 hr) rescued the effect of small interfering RNA (siRNA)-mediated knockdown of GluN2B in cultures ( Figure 5D ). Together, these data strongly suggest that the cellular mechanisms underlying these two forms of homeostatic synaptic plasticity are dissociable but also that NMDAR-mediated suppression of translation is likely mediated specifically by GluN2B signaling, and the downstream cellular signaling pathways responsible for this regulation are not activated by GluN2A-containing NMDARs.
GluN2B-Containing NMDARs Regulate Phosphorylation of p70S6K via mTOR Supporting our conclusion that GluN2B directly, and negatively, regulates local protein translation in dendrites, both western blot analysis and immunostaining revealed a strong increase in levels of phosphorylated p70 ribosomal S6 kinase (p70S6K) in 2B/2A cultures relative to WT controls ( Figures 6A and S5) . Levels of phosphorylated p70S6K correlate positively with the degree of active protein synthesis in neurons and are positively regulated by mTOR. To test the potential role of mTOR in acute scaling, we applied TTX + APV either in the presence or the absence of the mTOR inhibitor rapamycin (1 mM). The results are consistent with a role for mTOR signaling in this scaling regime, because exposure to rapamycin completely blocked the predicted increase in mEPSC amplitudes and levels of phosphorylated p70S6K ( Figures 6B and 6C) . To test the potential interaction between GluN2B signaling and the mTOR pathway, we applied rapamycin to WT control neurons and neurons expressing a plasmid-encoded siRNA directed against GluN2B (siRNAGluN2B). In both cases, rapamycin significantly reduced mEPSC amplitudes, suggesting that (1) basal levels of activity are insufficient to suppress all mTOR signaling, and (2) increased mEPSC amplitudes in GluN2B null neurons are, at least in part, due to activation of mTOR signaling ( Figure 6D) .
To understand the cellular signaling mechanisms responsible for the specificity of GluN2B function, we performed loss-offunction mutation rescue experiments in rat cortical cultures. In cultures from E18 cortices, we transfected neurons at 8DIV with siRNA-GluN2B and a GFP reporter. Suppression of GluN2B expression in individual cortical neurons resulted in a significant, and multiplicative, increase in AMPAR-mediated current at excitatory synapses, as evidenced by the increase in mEPSC amplitudes 4 days later ( Figures 7A and 7B ). The effect of GluN2B knockdown was specific because it could be rescued by cotransfection with WT GluN2B ( Figure 7C ) . GluN2A and GluN2B are highly similar proteins (70% homology in primary protein structure), with the highest degree of diversity within the COOH tail. Whereas the COOH tails determine unique intracellular interactions, the extracellular protein domain, in large part, determines the difference in current kinetics. We therefore tested whether or not the GluN2B COOH terminal was required for proper regulation of AMPARmediated currents by cotransfecting a chimeric subunit containing the GluN2B extracellular N-terminal domain and the GluN2A intracellular C-terminal domain (2ACterm) (Gallagher et al., 1996) . In these experiments, the chimeric receptor was unable to rescue the effect of siRNA-GluN2B (siRNA alone = 14.43 ± 0.75 pA, n = 24; siRNA-GluN2B + 2ACterm = 12.95 ± 1.43 pA, n = 14, p = 0.37), suggesting a critical role for this protein domain. Interestingly, the reciprocal chimeric receptor, having the GluN2A N-terminal domain and GluN2B C-terminal domain (2BCterm), only partially rescued the effect of siRNA-GluN2B (siRNA-GluN2B + 2BCterm chimera = 12.03 ± 1.04 pA, n = 14). Taken together, these data suggest that both the current kinetics and downstream signaling interactions unique to GluN2B are critical.
GluN2B-Mediated Regulation of AMPAR Current Requires Interaction with CaMKII
An important kinase that preferentially associates with the COOH terminus of GluN2B over GluN2A is CaMKII (Strack et al., 2000; Barria and Malinow, 2005) . To test the importance of this interaction, we cotransfected siRNA-GluN2B along with a mutant GluN2B receptor that does not interact with CaMKII (RS/QD: R1300Q; S1303D) (Bayer et al., 2001) . When compared with neurons coexpressing WT GluN2B, the RS/QD mutant was unable to reverse the siRNA-mediated increase in AMPAmEPSC amplitudes ( Figure 7C ). The similar increase in mEPSC amplitudes in siRNA-expressing cells and cells expressing both siRNA and the CaMKII binding mutant suggests that GluN2B-mediated suppression of synaptic AMPAR incorporation requires interaction between GluN2B and CaMKII.
Consistent with a role for CaMKII activation, we observed that phosphorylation of CaMKII at T286 is significantly reduced in GluN2B null neuronal dendrites ( Figure 7D ). Moreover, cotransfection of siRNA-GluN2B along with the CaMKII constitutively active mutant CaMKII T286D (Fong et al., 1989) , but not WT CaMKII or the nonphosphorylatable mutant T286A, was able to rescue GluN2B loss of function ( Figures 7E and 7F ). These data suggest that both proper localization and activation of CaMKII downstream of GluN2B are critical for maintaining appropriate levels of AMPARs at developing cortical synapses. The decrease in levels of phosphorylated CaMKII was not due to a decrease in total CaMKII protein, because this was actually enhanced in the dendrites of siRNA-GluN2B-expressing neurons ( Figure 7D ).
Another important protein effector of NMDAR function is the synaptically localized GTPase activating protein, SynGAP. SynGAP has been shown to interact preferentially with GluN2B-containing NMDARs, and the phenotype of the SynGAP knockout animal is strikingly similar to the GluN2B knockout (Kim et al., 2003; Vazquez et al., 2004; Kim et al., 2005; Kutsuwada et al., 1996) . We examined SynGAP expression and function in the 2B/2A mouse, hypothesizing that it could be a major effector of GluN2B signaling at glutamatergic synapses. Consistent with previous reports, we observed a significant decrease in mean mEPSC amplitudes in neurons transfected with WT fulllength SynGAP (Figures S6A and S6B ). From this we inferred that if SynGAP-mediated regulation of AMPAR trafficking acted downstream of GluN2B, coexpression of SynGAP would rescue 
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Developmental Role of GluN2B-Containing NMDARs GluN2B loss of function. However, overexpression of SynGAP did not rescue mEPSC amplitudes recorded in GluN2B-siRNAexpressing neurons ( Figure S6B ). Furthermore, we tested the requirement for SynGAP activation in this system by cotransfecting neurons with 2BsiRNA + CaMKII T286D and siRNA against SynGAP. SynGAP siRNA did not block the rescue induced by CaMKII T286D, and in neurons expressing 2BsiRNA and SynGAP siRNA, we observed an additive increase in mEPSC amplitudes ( Figure S6D ). Together, these data suggest that although SynGAP can regulate AMPAR content at developing synapses, it is not a strong candidate for effecting GluN2B signaling and regulating homeostatic synaptic plasticity.
Developmentally Expressed GluN2B-Containing NMDARs Are Required for Normal Social Behaviors NMDARs are critical for proper circuit development, and suppression of NMDAR function during development can be genetically induced via decreased expression of the obligatory GluN1 subunit (GluN1 hypomorph) (Mohn et al., 1999) . This manipulation results in a behavioral phenotype marked by hyperlocomotion and decreased sociability. Due to the strong synaptic phenotype we observed in the 2B/2A mice, we wondered whether the changes observed in the GluN1 hypomorph animal might be attributable to specific loss of GluN2B function during development. In support of this hypothesis, 2B/2A animals exhibited increased spontaneous locomotion in a familiar cage setting when measured P15-P21 (cage transect counts per 3 min) ( Figure 8C ). Observation of homozygous 2B/2A animals also revealed that these animals interact less frequently with their littermates than control animals. To determine whether this reflected a deficit in exploratory social behavior, we used a social approach assay after weaning (P15-P26) (Silverman et al., 2010) . None of the genotypes (WT/ HET/2B/2A) showed preference during the object exploration phase, as shown by the average Dt values around 0 s ( Figure 8A ). However, in the test phase, WT and HET animals then spent significantly more time exploring the bottle containing the mouse ( Figure 8A ). In contrast, 2B/2A mice showed a striking Locomotor and social behaviors were tested in homozygous 2B/2A animals and compared with WT, heterozygous 2B/2A (HET), nutrient-deprived (ND), and cortex-restricted GluN2B knockout mice (2BDCtx). (A) In a social approach assay, none of the genotypes or conditions showed preference for object exploration when presented with two identical objects. Homozygous 2B/2A mice failed to match littermate control animals in demonstrating a predicted and statistically significant increased preference for social exploration when an age-matched juvenile animal was introduced inside one of the objects. 2BDCtx mice also showed significantly altered behavior on this task, although their performance was statistically significant from 2B/2A animals (* represents compared to WT; # indicates compared to 2B/2A). (B) In a second sociability test, both 2B/2A and 2BDCtx animals showed significantly higher times in returning to social huddles following physical isolation. (C) Differences could not be attributed to decreased motor function because both 2B/2A and 2BDCtx animals exhibited increased levels of spontaneous locomotor activity. (D) To control for potential changes due to differences in animal size and/or nutritional state, we subjected a subset of WT animals to nutrient deprivation (ND). Although the size of these animals was brought to 2B/2A levels, they did not show similar change in social behaviors (A-C). suppression in social approach times, as seen by the Dt scores on the second phase of this task ( Figure 8A ). Additional observation of homozygous 2B/2A mice revealed an apparent increase in time spent isolated from their cage mates. Preweanling WT and HET animals exhibited a characteristic social behavior when housed together, in which littermate animals rested in a huddle. We measured the time required for individual mice to return unimpeded to a social huddle following removal to the opposite corner of their home cage. We observed a significant increase in the amount of time it took for 2B/2A mice to return following physical isolation ( Figure 8B ). In fact, a subset of the 2B/2A animals tested did not return within the time allotted for the test (150 s). The 2B/2A animals' ability to see and smell was evident by their reaction to attempted physical contact and their ability to locate food and water. We also tested the potential confound of decreased nutrition in these animals by restricting wild-type animals from food in order to stunt their growth to a similar degree. Interestingly, although nutrient deprivation (ND) was successful in reducing body mass in WT mice to levels similar to 2B/2A mice, it did not mimic changes observed in social behavioral tests (Figure 8 ), in spite of the fact that this manipulation has previously been shown to suppress social exploratory behaviors (Almeida and De Araú jo, 2001) . In that previous report, however, malnutrition was continued for a longer period.
Another important question is, are these behavioral changes the result of GluN2B loss of function or of premature expression of GluN2A? To clarify this, we performed behavioral analysis using a GluN2B conditional knockout mouse (Brigman et al., 2010) . This allowed us to compare the social phenotype of animals lacking GluN2B (2BDCtx) to 2B/2A animals expressing GluN2A in the absence of GluN2B. We used the NexCre mouse to rescue GluN2B function in subcortical regions and restrict gene excision to primary neurons of the neocortex and hippocampus (Goebbels et al., 2006) . Interestingly, we observed very similar phenotypes in the 2BDCtx mice in terms of hyperlocomotion and altered social behavior (Figure 8 ). Although these data suggest that the social phenotype might be due primarily to cortical loss of GluN2B, and not to premature expression of GluN2A, they also revealed that 2B/2A mice perform significantly worse on the social exploration task than 2BDCtx animals ( Figure 8A ). From this we conclude that these social deficits are not due simply to malnourishment and that the majority of the behavioral phenotype can be attributed to loss of GluN2B, although it is possible that premature expression of GluN2A enhances the deficit in social exploration.
DISCUSSION
The primary observation from these studies is that GluN2B-mediated signaling during development cannot be rescued by premature expression of the mature NMDAR subunit GluN2A. This provides strong evidence that these subunits serve distinct functional roles. In terms of synaptic function, we show that GluN2B-containing NMDARs are necessary for appropriate regulation of AMPAR-mediated currents and play a critical role in protein translation-dependent homeostatic plasticity. Additionally, our data suggest that their unique interaction with CaMKII is responsible for the distinct cellular signaling associated with GluN2B-containing NMDARs and that suppression of protein translation by these receptors involves the mTOR pathway. Interestingly, a recent report has shown that rapid antidepressant effects of NMDAR antagonists involve activation of the mTOR pathway and rapid stabilization of cortical synapses . The data presented here provide evidence that this may be due to disruption of GluN2B signaling, which acts via mTOR to suppress local protein synthesis in cortical dendrites.
A Critical Role for GluN2B-Containing NMDARs during Cortical Development GluN2B knockout mice die at P0, and this has largely precluded studies of the role of this subunit during development (Kutsuwada et al., 1996) , whereas the absence of any dramatic survival phenotype in GluN2A null mice is consistent with their weak expression during embryogenesis and early postnatal periods (Sakimura et al., 1995) . Recent reports have presented data from conditional GluN2B knockout mice; however, these studies have largely focused on the consequences of genetic removal after initial circuit formation (Brigman et al., 2010; von Engelhardt et al., 2008; Akashi et al., 2009) . In light of this and of evidence that GluN2B may be uniquely required for proper localization of plasticity-related signaling molecules at excitatory synapses (Foster et al., 2010) , we focused on examining the specific role of GluN2B during early postnatal development.
During this period, homeostatic synaptic plasticity is required to maintain neuronal excitability within a physiologically appropriate range, because both the number of synapses onto individual neurons and sensory-driven activity increases in cortical networks. Homeostatic synaptic plasticity controls synapse excitability in a bidirectional manner, in part by regulating incorporation of synaptic AMPARs (Turrigiano, 2008) . Scaling up synaptic AMPAR contribution in response to chronic suppression of neuronal activity has been shown to be dependent upon transcription but independent of NMDAR function (Turrigiano, 2008) . In support of this, we found that scaling in response to chronic TTX treatment was intact in both GluN2B null and 2B/2A neurons. Relatively rapid homeostatic scaling up of synapses can also be evoked acutely by blocking NMDARmediated suppression of local protein translation. This increase in AMPAR-mediated current results from activation of local protein synthesis and increased availability of AMPAR subunits (Ju et al., 2004; Sutton et al., 2004 Sutton et al., , 2006 . We found that protein translation-dependent scaling is occluded in the absence of GluN2B and is not rescued in 2B/2A neurons, suggesting that NMDAR-mediated suppression of protein translation is subunit specific. From this we infer that a dominant role for GluN2B-containing NMDARs during development is to maintain appropriate levels of protein translation in dendrites in order to regulate synapse excitability. Consistent with this, we observed increased levels of phosphorylated S6K in dendrites lacking GluN2B and increased surface expression of AMPAR subunits GluA1 and GluA2 in dendrites of GluN2B null neurons . mRNAs encode GluA1 and GluA2 traffic to dendrites, where their translation is locally regulated. Interestingly, antagonism of GluN2B-containing NMDARs results in upregulation of synaptic protein translation in vivo through activation of the mTOR pathway . This suggests that it is through regulation of local protein synthesis that GluN2B antagonists may exert their effects as strong antidepressants (Maeng et al., 2008; Preskorn et al., 2008; Li et al., 2010) . It will be critically important to determine the exact molecular mechanism by which NMDARs, and specifically GluN2B, regulate protein synthesis in neuronal dendrites and to identify the RNA messages involved.
GluN2B-Containing NMDAR Function Is Mediated by CaMKII
Our experiments suggest that the specificity of GluN2B function is mediated through its preferential association with CaMKII. Regulation of AMPAR-mediated currents at developing cortical synapses requires CaMKII function downstream of GluN2B, because expression of a subunit mutant unable to interact with CaMKII is ineffective at rescuing GluN2B loss of function. Importantly, although we observed that levels of activated (phosphorylated) CaMKII are depressed in the absence of GluN2B signaling, we actually observed an increase in the protein expression levels of this kinase and a decrease in the levels of beta CaMKII (data not shown). Interestingly, bidirectional homeostatic synaptic plasticity has been shown to involve reciprocal regulation of alpha and beta CaMKII (Thiagarajan et al., 2002; Groth et al., 2011) . Thus, it will be important in future studies to determine the exact conditions and mechanisms by which these enzymes are regulated by GluN2B and GluN2A-mediated signaling. Because of its role in NMDAR-mediated long-term potentiation (LTP), the observation that CaMKII may also play a critical role in suppressing AMPAR insertion at developing synapses may at first seem contradictory; however, this can be rectified by the following two, nonmutually exclusive, predictions: (1) basal activation of GluN2B-containing NMDARs suppresses AMPAR contribution through weak activation of CaMKII, whereas strong activation leads to a dissociation of this mechanism and increased AMPAR contribution, and/or (2) LTP at young cortical synapses relies on protein kinase A, whereas CaMKII plays a larger role at mature synapses (Yasuda et al., 2003) . Furthermore, due to its early dominance, GluN2B probably plays a more significant role during synapse formation in the cortex, and signaling via this subunit may actually decrease in prominence due to increased expression of GluN2A subunits and the formation of triheteromeric receptors or through the movement of GluN2B-containing NMDARs to perisynaptic regions. Reports suggest that the majority of NMDARs in the mature hippocampus are in fact triheteromeric (Rauner and Kohr, 2011) . It is thus plausible that one consequence of the increase in GluN2A expression is suppression of the availability of GluN2B-containing receptors. The idea that these aspects of GluN2B function dominate developing synapses and decrease with age is supported by recent reports in which GluN2B was removed after initial cortical circuit development using a conditional GluN2B knockout animal. In these experiments, no change in AMPAR-mediated mEPSC amplitudes was observed (von Engelhardt et al., 2008).
GluN2B-Containing NMDARs and SynGAP
In addition to a potential role for CaMKII in defining GluN2B function, vis a vis GluN2A, we also tested the role of the synaptic G protein activating enzyme SynGAP, which associates preferentially with GluN2B over GluN2A (Kim et al., 2005) . The phenotype of the SynGAP knockout animal is strikingly similar to that of the GluN2B null: homozygous knockout animals die at early postnatal ages but exhibit increased AMPAR contribution at cortical synapses (Kutsuwada et al., 1996; Kim et al., 2003; Vazquez et al., 2004; Rumbaugh et al., 2006) . Additionally, heterozygous SynGAP animals show a behavioral phenotype consistent with schizophrenia-like symptoms in mice, including a preference for social isolation and hyperlocomotion (Guo et al., 2009) . These data are supportive of the conclusion that SynGAP may be a major effector of GluN2B function; however, although our data confirmed that overexpression of SynGAP at cortical synapses drives down AMPAR-mediated currents, SynGAP overexpression was unable to rescue GluN2B loss of function as predicted. Because CaMKII is a strong activator of SynGAP (Oh et al., 2004) , we inferred that this might be due to decreased CaMKII function. However, suppression of SynGAP activity via siRNA knockdown did not block the rescue of GluN2B loss of function by constitutively active CaMKII (T286D), suggesting that these enzymes may act via parallel pathways or may function at independent synapses. This remains to be fully resolved, yet, it is important to note that GAP proteins are known to regulate translation in neurons: the GAP domain-containing protein TSC2, which associates with TSC1, directly regulates mTOR function (Hoeffer and Klann, 2010) .
GluN2B Loss of Function and Schizophrenia-like Behaviors in Mice
NMDARs have been implicated in numerous cellular processes and psychiatric disorders. Studying behavioral effects of NMDAR antagonism in humans has led to the hypothesis that glutamatergic synapse dysfunction may be the root cause of schizophrenia (Belsham, 2001; Moghaddam, 2003) . In addition, suppression of NMDAR function during development recapitulates schizophrenia-like symptoms in adult mice (Stefani and Moghaddam, 2005) . Supporting a hypoglutamate hypothesis of schizophrenia, mice with suppressed NMDAR function have been generated as effective animal models of this disorder (Mohn et al., 1999; Belforte et al., 2010) . One of these, the GluN1 hypomorph mouse, exhibits a phenotype that includes hyperlocomotion and altered sociability. Because of the lethality associated with the GluN2B global knockout mouse, the role of GluN2B in the expression of this behavioral phenotype had not been tested. GluN1 hypomorph animals exhibit a reduction in total NMDAR expression to approximately 5%-10%. In contrast, in 2B/2A homozygous animals, approximately 60% of the integrated cortical NMDAR current is recovered, but it is now mediated purely by GluN2A-contaning NMDARs. Interestingly, this manipulation recapitulates a behavioral phenotype of hyperlocomotion and altered sociability. This predicts that aspects of the behavioral phenotype associated with suppressed NMDAR dysfunction in the GluN1 hypomorph may be specifically due to a loss of GluN2B-containing NMDAR signaling during development. We also show that developmental excision of GluN2B in primary cortical and hippocampal neurons (2BDCtx) recapitulates aspects of the phenotype observed in the 2B/2A animal. It has previously been shown that suppression of NMDAR function in cortical and hippocampal GABAergic interneurons results in schizophrenia-like symptoms in mice (Belforte et al., 2010) . Although future experiments are needed to compare and contrast the phenotypes of these animals, data suggest that changes in corticolimbic excitatory and inhibitory balance may underlie these behavioral alterations.
In summary, our experiments show that GluN2B is a critical regulator of homeostatic synaptic plasticity and social behavior. They demonstrate that GluN2A, in spite of being functionally expressed in the absence of GluN2B at cortical synapses, is unable to rescue GluN2B loss of function. We infer that a major function of GluN2B-containing NMDARs is to suppress local protein translation in dendrites through interaction with downstream signaling molecules, including alpha-CaMKII and the mTOR pathway. 
Cell Culture
Cell cultures were prepared as previously described .
GluN2B KO Mice
GluN2B null, heterozygous, and wild-type mouse cultures were generated from E16-E17 mouse embryos derived from heterozygous GluN2B matings (Kutsuwada et al., 1996) .
Genetic Replacement of GluN2B by GluN2A
To generate the 2B/2A targeting construct, we isolated a portion of the sixth chromosome from a phage-based library of wild-type-129 mouse DNA, probing for the initial coding exon of the GluN2B gene (429 bp-exon 4). The cloned fragment (pD1) was z14 kbp in length and contained the entire exon. From pD1, a 7.3 kbp fragment, including 4.3 kbp of 3 0 flanking sequence, was excised. This was cloned into a pBluscript vector to generate pBluD1_N/B. The 2B/2A targeting construct contained (from 5 0 to 3 0 ) an intronic flanking region, the first z70 bp of exon 4, full-length cDNA for rat GluN2A, and a loxP flanked neo selection cassette. The introduced GluN2A cDNA removed most of exon 4, including the initial ATG, resulting in nonsense transcript downstream of the GluN2A coding sequence. The construct was confirmed by restriction digest and PCR analysis, then purified and introduced into WT-129 (male) mouse embryonic stem cells (ESCs). ESCs were selected for neomycin resistance, and homologous recombination was confirmed using an upstream genomic probe that identified incorporation of the targeting construct by predicted size shift in Southern blots. Positive clones were karyotyped and injected into pseudopregnant C57/B6 mice. Male chimeric offspring were bred with pure C57/B6 mice to assess germline transmission. Propagation of the targeted alleles was confirmed and followed by PCR analysis. Primers for genotyping were the following: WT forward TTCTCCCAAGTT CTGGTTG, WT reverse GATGCGGGTGATTATGCT, 2B/2A forward CCTCC TGGTGTTTCCAGTGT, and 2B/2A reverse GCGACTCTCAGACCTCATCC.
GluN2B Conditional KO Mice
Cortical GluN2B KO was accomplished by crossing animals containing a loxP flanked exon 5 (Brigman et al., 2010 ) with mice expressing Cre-recombinase under the cortex specific Nex locus (Goebbels et al., 2006) . GluN2B flox/+ ; Nex-Cre/+ mice were crossed with GluN2B flox/+ or GluN2B flox/flox mice to obtain GluN2B flox/flox ; Nex-Cre/+ mice, which are referred to as 2BDCtx mice. Mice that were GluN2B flox/+ and GluN2B flox/flox but WT at the Nex locus served as controls.
Electrophysiology
Synaptic activity was recorded from cell cultures and acute brain slices while perfused at room temperature in a bicarbonate buffered solution containing 124 mM NaCl, 5 mM KCl, 26 mM NaHCO 3 , 1.23 mM NaH 2 PO 4 , 1.5 mM MgCl 2 , 2 mM CaCl 2 , and 10 mM glucose and bubbled constantly with 95% O 2 /5% CO 2 . Voltage-clamp recordings were made using glass microelectrodes (borosilicate glass 1.5 mm outer diameter and 0.86 mm inner diameter, Warner Instruments, Hamden, CT), pulled on a micropipette puller (FlamingBrown P-80/PC, Sutter Instrument , Novato, CA), and filled with a cesiumsubstituted intracellular solution containing 10 mM CsCl, 105 mM CsMeSO 3 , 8 mM NaCl, 0.5 mM ATP, 0.3 mM GTP, 10 mM HEPES, 5 mM glucose, 2 mM MgCl 2 , and 1 mM EGTA (pH 7.3). Pipette resistances ranged 3-13 MU. Series access resistance ranged from z7 to 35 MU and was monitored for consistency. Signals were recorded using a patch-clamp amplifier (PC505B, Warner Instruments) and digitized with a BNC-2111 A/D board (National Instruments, Austin, TX) using custom-written software in Igor Pro (WaveMetrics, Lake Oswego, OR). Signals were amplified, sampled at 10 kHz, filtered to 2 or 5 kHz, and analyzed using custom routines in Igor Pro. TTX, APV, and picrotoxin were all from Tocris Bioscience (Ellisville, MO). GluN2B-siRNA used in these studies was previously described . All recordings were performed on pyramidal neurons. In slice recordings, layer II pyramidal neurons were targeted for recording, and slices of cortex were within two sections (700 mm) of the primary somatosensory cortex, as evident by the presence of barrel structures, observable in live differential interference contrast images. Synaptic responses were evoked using concentric bipolar stimulating electrodes placed in layer IV (Frederick Haer, Bowdoin, ME). Current was evoked with a stimulus isolation unit (Cygnus Technology, Delaware Water Gap, PA) controlled by a PG4000A digital stimulator (Cygnus Technology). For local NMDA stimulation (Figures 2 and S2D) , glass electrodes of similar resistance (z5 MU) were filled with agonist (NMDA and D-serine) in artificial cerebral spinal fluid, to which we applied short (10-60 ms), repetitive (10 s intervals) pressure stimulation (18 psi), using a Picospritzer II (General Valve, Fairfield, NJ).
Immunohistochemistry
All of the following antibodies were used at 1:1,000 dilution: anti-CaMKII (Abcam), anti-phosphoCaMKII (Abcam), anti-GluN2A (Millipore), and antiGluN2B (University of California, Davis/National Institutes of Health NeuroMab Facility clone number 59/20). Surface staining was performed as previously described .
Behavioral Assays
All behavioral testing was conducted at the beginning of the animals' 12 hr dark cycle under low ambient light. Detailed methods for these tests are presented in the Supplemental Experimental Procedures.
Statistical Analysis
Statistical significance was confirmed by t test comparison of mean values obtained from each genotype (or experimental condition) compared to control. All data (text and figures) are presented as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at doi:10.1016/j.neuron. 2011.09.023.
